These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3290536)

  • 1. [Allogeneic bone marrow transplantation for acute leukemia in children].
    Horibe K; Kojima S; Matsuyama T; Hirata R; Yoshida J; Kato K; Yoshida M; Iwamura H
    Rinsho Ketsueki; 1988 Feb; 29(2):123-9. PubMed ID: 3290536
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of allogeneic bone marrow transplantation in patients with acute leukemia during first remission].
    Takemoto Y; Shinohara Y; Fujimori Y; Andoh S; Akagi T; Okuda K; Okada Y; Kobaba R; Sawada C; Inoue N
    Rinsho Ketsueki; 1988 Nov; 29(11):2018-23. PubMed ID: 3070072
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
    Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic marrow transplantation in children with acute leukemia: careful comparison with chemotherapy alternatives required.
    Pulsipher MA; Hunger SP; Gamis AS; Wall DA; Grupp SA
    Leukemia; 2010 Jun; 24(6):1212-6. PubMed ID: 20428198
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogeneic bone marrow transplantation in the treatment of acute leukemias of children. Study of 26 patients].
    Michel G; Maraninchi D; Perrimond H; Mascret B; Orsini A; Gastaut JA; Raybaud C; Blaise D; Demeocq F; Sebahoun G
    Arch Fr Pediatr; 1986 Dec; 43(10):769-74. PubMed ID: 3548633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful allogeneic bone marrow transplantation for three children with acute nonlymphocytic leukemia.
    Ohira M; Takayama J; Hanada M
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():487-93. PubMed ID: 6097709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
    Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Seo EJ; Park CJ; Chi HS; Lee JS
    Bone Marrow Transplant; 2003 Oct; 32(8):835-42. PubMed ID: 14520431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome.
    Leung W; Pitts N; Burnette K; Cunningham JM; Horwitz EM; Benaim E; Hale G; Woodard P; Pui CH; Bowman LC
    Bone Marrow Transplant; 2001 Apr; 27(7):717-22. PubMed ID: 11360111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
    Min CK; Eom KS; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 May; 27(9):999-1005. PubMed ID: 11436112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical analysis of favorable prognostic factors in allogeneic bone marrow transplantation for acute leukemia in Japan.
    Inoue T; Masaoka T; Mori T; Katoh S; Saito Y; Harada M; Saito M; Moriyama Y; Ohira M; Morita K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():563-71. PubMed ID: 6394817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.